Benefits
144× Bioavailability vs Standard Curcumin
Curcuwin Ultra+ is 144× more bioavailable compared to standard curcumin — one capsule (250/500 mg) equivalent to 30 capsules of standard curcumin/turmeric powder.
40% Faster Absorption
Curcuwin Ultra+ absorbed 40% faster than standard curcumin — supports rapid clinical effects.
Joint Health for Knee OA (5-Day Onset)
Multi-centric RCT of 134 adults with mild knee OA showed Curcuwin Ultra+ provides improvements in joint comfort, function, range of motion, knee muscle strength, and quality of life — with effects appearing in as early as 5 days.
Reduced Rescue Medication Use
Same trial: significant reduction in frequency of rescue medication use compared to placebo — practical clinical benefit.
Heart Health and Sports Nutrition
Curcuwin Ultra+ inherits clinically supported heart health and sports nutrition benefits from original Curcuwin (same Ultrasol foundational technology).
Convenient Low-Dose
One capsule daily provides effects requiring 30 capsules of standard curcumin — convenience advantage.
Versatile Formulation
Excellent organoleptic profile allows incorporation into challenging applications including gummies and beverages.
Mechanism of action
Ultrasol Technology with Bioenhancers
Curcuwin Ultra+ formulated using specialized process incorporating bioenhancers to better protect and deliver more curcuminoids than standard curcumin.
144× Bioavailability Enhancement
Multi-component approach addresses curcumin's primary clinical limitation (poor absorption); delivers significantly more active curcuminoids to systemic circulation.
NF-kB and Multiple Inflammatory Pathway Modulation
Same fundamental anti-inflammatory mechanism as other curcumin; bioavailability advantage delivers more active to inflammation sites.
Cartilage and Joint Tissue Effects
Effects on inflammation, oxidative stress, and matrix metalloproteinases relevant to cartilage health.
Sustained 84-Day Efficacy
Joint health benefits continue and build through 84-day supplementation period.
Clinical trials
Multi-centric, randomized, double-blind, parallel, placebo-controlled study of Curcuwin Ultra+ at 250 mg (50 mg curcuminoids) or 500 mg (100 mg curcuminoids) vs placebo for 84 days in 134 adults with mild knee OA.
134 adults with mild knee osteoarthritis.
Both doses significantly reduced discomfort scores and rescue medication frequency vs placebo; improved knee muscle strength, range of motion, quality of life. Effects appeared as early as 5 days. Published in Journal of Orthopedic Research and Therapy.
PK studies comparing Curcuwin Ultra+ vs standard curcumin.
Healthy adults.
144× greater bioavailability; 40% faster absorption.
About this ingredient
CURCUWIN ULTRA+® is OMNIACTIVE's HIGHLY BIOAVAILABLE CURCUMIN ingredient — formulated using ULTRASOL technology with BIOENHANCERS.
KEY DISTINCTIONS: (1) 144× BIOAVAILABILITY vs standard curcumin; (2) 40% FASTER absorption; (3) ONE CAPSULE = 30 standard curcumin capsules; (4) 5-DAY ONSET for joint applications; (5) 134-PARTICIPANT KNEE OA RCT with 84-day duration; (6) Excellent organoleptic profile for diverse applications (gummies, beverages); (7) Inherits original Curcuwin's heart and sports nutrition evidence; (8) Published in Journal of Orthopedic Research and Therapy.
EVIDENCE-BASED USES: (1) Knee osteoarthritis joint comfort (5-day onset); (2) Joint function, range of motion, muscle strength; (3) Reduced rescue medication use; (4) Heart health (inherited from original Curcuwin); (5) Sports nutrition (inherited); (6) Healthy aging; (7) Anti-inflammatory across applications.
CRITICAL CAUTIONS: (1) GALLSTONES — curcumin cholagogue; AVOID; (2) PREGNANCY — concentrated curcumin AVOID high-dose; (3) ANTICOAGULANTS — modest effects; (4) PRE-SURGERY — discontinue 1-2 weeks; (5) DOSE — 250 mg (50 mg curcuminoids) or 500 mg (100 mg curcuminoids) — much lower curcuminoid amounts than typical curcumin products due to bioavailability; (6) CURCUWIN ULTRA+ vs MERIVA vs LONGVIDA vs CURQFEN vs HYDROCURC vs TURMIPURE GOLD — six major bioavailable curcumin technologies; CURCUWIN ULTRA+ has highest bioavailability claim (144×); LONGVIDA brain-targeted (UCLA neuroscientists); MERIVA most clinical evidence; CURQFEN BBB-permeable (347×); each with specific advantages; (7) BIOAVAILABILITY COMPARISON CONTEXT — different curcumin products use different reference standards, time intervals, and metabolite measurements; consumers should focus on overall ingredient credibility rather than competing bioavailability numbers; (8) FOR JOINT HEALTH — fast-onset (5-day) particularly useful for those wanting quick effects; lifestyle (exercise, weight management) foundational; (9) BRAND VERIFICATION — Curcuwin Ultra+® is OmniActive trademark; specific Ultrasol technology; clinical evidence on this branded form; (10) Among the most premium curcumin formulations with strong specific clinical research.